MARASCA, CLAUDIO
MARASCA, CLAUDIO
Dipartimento di Medicina clinica e Chirurgia
Biologics for patients affected by Hidradenitis suppurativa in the COVID-19 era: data from a referral centre of Southern Italy
2022 Marasca, Claudio; Ruggiero, Angelo; Megna, Matteo; Annunziata, Maria Carmela; Fabbrocini, Gabriella
Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a psoriasis patient. Comment on "Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab"
2023 Martora, Fabrizio; Fabbrocini, Gabriella; Marasca, Claudio; Battista, Teresa; Megna, Matteo
The effect of the ketogenic diet on Acne: Could it be a therapeutic tool?
2023 Barrea, Luigi; Cacciapuoti, Sara; Megna, Matteo; Verde, Ludovica; Marasca, Claudio; Vono, Rosa; Camajani, Elisabetta; Colao, Annamaria; Savastano, Silvia; Fabbrocini, Gabriella; Muscogiuri, Giovanna
Cutaneous adverse reaction following COVID-19 vaccination: Report from a southern Italian referral centre. Comment on "cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine" by Luo et al
2023 Martora, Fabrizio; Villani, Alessia; Marasca, Claudio; Fabbrocini, Gabriella; Ruggiero, Angelo
How Adalimumab Impacts Antibiotic Prescriptions in Patients Affected by Hidradenitis Suppurativa: A 1-Year Prospective Study and Retrospective Analysis
2023 Martora, Fabrizio; Marasca, Claudio; Picone, Vincenzo; Fornaro, Luigi; Megna, Matteo; Fabbrocini, Gabriella
Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience
2023 Martora, Fabrizio; Megna, Matteo; Battista, Teresa; Potestio, Luca; Annunziata, Maria Carmela; Marasca, Claudio; Villani, Alessia; Fabbrocini, Gabriella
The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review
2022 Ruggiero, Angelo; Martora, Fabrizio; Fabbrocini, Gabriella; Villani, Alessia; Marasca, Claudio; Megna, Matteo; Fornaro, Luigi; Comune, Rosita; Potestio, Luca
Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature
2022 Martora, Fabrizio; Battista, Teresa; Marasca, Claudio; Genco, Lucia; Fabbrocini, Gabriella; Potestio, Luca
Management of patients with hidradenitis suppurativa during COVID-19 vaccination: an experience from southern Italy. Comment on: 'Evaluating the safety and efficacy of COVID-19 vaccination in patients with hidradenitis suppurativa'
2022 Martora, Fabrizio; Marasca, Claudio; Battista, Teresa; Fabbrocini, Gabriella; Ruggiero, Angelo
Herpes Zoster and Alopecia Areata following mRNA BNT162b2 COVID-19 vaccine: Controversial immune effects
2022 Martora, Fabrizio; Fornaro, Luigi; Picone, Vincenzo; Marasca, Dario; Gargiulo, Maurizio; Annunziata, Maria Carmela; Fabbrocini, Gabriella; Marasca, Claudio
Generalized versus localized vitiligo after ixekizumab: May previous treatment affect the clinical presentation?
2022 Martora, Fabrizio; Battista, Teresa; Fornaro, Luigi; Fabbrocini, Gabriella; Megna, Matteo; Picone, Vincenzo; Marasca, Claudio
Step by step surgery for Hidradenitis Suppurativa
2022 Di Guida, Adriana; Patrizia, Forgione; Fornaro, Luigi; Marasca, Dario; Fabbrocini, Gabriella; Marasca, Claudio
Reply to 'Cutaneous adverse effects of the available COVID-19 vaccines in India: A questionnaire-based study' by Bawane J et al
2022 Potestio, L; Genco, L; Villani, A; Marasca, C; Fabbrocini, G; Fornaro, L; Ruggiero, A; Martora, F
Tacrolimus ointment may improve the effectiveness of adalimumab in patients with hidradenitis suppurativa: a novel promising treatment
2022 Ruggiero, Angelo; Marasca, Claudio; Villani, Alessia; Fabbrocini, Gabriella; Martora, Fabrizio
Hair removal and deodorants in hidradenitis suppurativa: an online survey on patients' habits
2022 Lauro, Wanda; Capasso, Gianmarco; Fabbrocini, Gabriella; Marasca, Claudio
Reply to 'A case of dystrophic epidermolysis bullosa pruriginosa treated with dupilumab' by Caroppo et al
2022 Martora, F; Fabbrocini, G; Nappa, P; Marasca, C; Patruno, C; Scalvenzi, M; Napolitano, M
Skin reaction after SARS-CoV-2 vaccines Reply to 'cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: A real-life multicentre experience'
2022 Martora, Fabrizio; Villani, Alessia; Marasca, Claudio; Fabbrocini, Gabriella; Potestio, Luca
Teledermatology in the management of hidradenitis suppurativa: Should we improve this service?
2022 Ruggiero, Angelo; Marasca, Claudio; Fabbrocini, Gabriella; Villani, Alessia; Martora, Fabrizio
Ultrasound: an indispensable tool to evaluate the outcome of surgical approaches in patients affected by hidradenitis suppurativa
2020 Marasca, Claudio; Marasca, Dario; Megna, Matteo; Annunziata, MARIA CARMELA; Fabbrocini, Gabriella
Strategies adopted in a southern Italian referral centre to reduce adalimumab discontinuation: comment on 'Can we increase the drug survival time of biologic therapies in hidradenitis suppurativa?'
2022 Martora, Fabrizio; Marasca, Claudio; Fabbrocini, Gabriella; Ruggiero, Angelo
Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
---|---|---|---|---|
Biologics for patients affected by Hidradenitis suppurativa in the COVID-19 era: data from a referral centre of Southern Italy | 1.1 Articolo in rivista | 2022 | Marasca, Claudio; Ruggiero, Angelo; Megna, Matteo; Annunziata, Maria Carmela; Fabbrocini, Gabriella | |
Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a psoriasis patient. Comment on "Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab" | 1.1 Articolo in rivista | 2023 | Martora, Fabrizio; Fabbrocini, Gabriella; Marasca, Claudio; Battista, Teresa; Megna, Matteo | |
The effect of the ketogenic diet on Acne: Could it be a therapeutic tool? | 1.1 Articolo in rivista | 2023 | Barrea, Luigi; Cacciapuoti, Sara; Megna, Matteo; Verde, Ludovica; Marasca, Claudio; Vono, Rosa; Camajani, Elisabetta; Colao, Annamaria; Savastano, Silvia; Fabbrocini, Gabriella; Muscogiuri, Giovanna | |
Cutaneous adverse reaction following COVID-19 vaccination: Report from a southern Italian referral centre. Comment on "cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine" by Luo et al | 1.1 Articolo in rivista | 2023 | Martora, Fabrizio; Villani, Alessia; Marasca, Claudio; Fabbrocini, Gabriella; Ruggiero, Angelo | |
How Adalimumab Impacts Antibiotic Prescriptions in Patients Affected by Hidradenitis Suppurativa: A 1-Year Prospective Study and Retrospective Analysis | 1.1 Articolo in rivista | 2023 | Martora, Fabrizio; Marasca, Claudio; Picone, Vincenzo; Fornaro, Luigi; Megna, Matteo; Fabbrocini, Gabriella | |
Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience | 1.1 Articolo in rivista | 2023 | Martora, Fabrizio; Megna, Matteo; Battista, Teresa; Potestio, Luca; Annunziata, Maria Carmela; Marasca, Claudio; Villani, Alessia; Fabbrocini, Gabriella | |
The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review | 1.1 Articolo in rivista | 2022 | Ruggiero, Angelo; Martora, Fabrizio; Fabbrocini, Gabriella; Villani, Alessia; Marasca, Claudio; Megna, Matteo; Fornaro, Luigi; Comune, Rosita; Potestio, Luca | |
Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature | 1.1 Articolo in rivista | 2022 | Martora, Fabrizio; Battista, Teresa; Marasca, Claudio; Genco, Lucia; Fabbrocini, Gabriella; Potestio, Luca | |
Management of patients with hidradenitis suppurativa during COVID-19 vaccination: an experience from southern Italy. Comment on: 'Evaluating the safety and efficacy of COVID-19 vaccination in patients with hidradenitis suppurativa' | 1.1 Articolo in rivista | 2022 | Martora, Fabrizio; Marasca, Claudio; Battista, Teresa; Fabbrocini, Gabriella; Ruggiero, Angelo | |
Herpes Zoster and Alopecia Areata following mRNA BNT162b2 COVID-19 vaccine: Controversial immune effects | 1.1 Articolo in rivista | 2022 | Martora, Fabrizio; Fornaro, Luigi; Picone, Vincenzo; Marasca, Dario; Gargiulo, Maurizio; Annunziata, Maria Carmela; Fabbrocini, Gabriella; Marasca, Claudio | |
Generalized versus localized vitiligo after ixekizumab: May previous treatment affect the clinical presentation? | 1.1 Articolo in rivista | 2022 | Martora, Fabrizio; Battista, Teresa; Fornaro, Luigi; Fabbrocini, Gabriella; Megna, Matteo; Picone, Vincenzo; Marasca, Claudio | |
Step by step surgery for Hidradenitis Suppurativa | 1.1 Articolo in rivista | 2022 | Di Guida, Adriana; Patrizia, Forgione; Fornaro, Luigi; Marasca, Dario; Fabbrocini, Gabriella; Marasca, Claudio | |
Reply to 'Cutaneous adverse effects of the available COVID-19 vaccines in India: A questionnaire-based study' by Bawane J et al | 1.7 Commento, erratum, replica e simili | 2022 | Potestio, L; Genco, L; Villani, A; Marasca, C; Fabbrocini, G; Fornaro, L; Ruggiero, A; Martora, F | |
Tacrolimus ointment may improve the effectiveness of adalimumab in patients with hidradenitis suppurativa: a novel promising treatment | 1.1 Articolo in rivista | 2022 | Ruggiero, Angelo; Marasca, Claudio; Villani, Alessia; Fabbrocini, Gabriella; Martora, Fabrizio | |
Hair removal and deodorants in hidradenitis suppurativa: an online survey on patients' habits | 1.1 Articolo in rivista | 2022 | Lauro, Wanda; Capasso, Gianmarco; Fabbrocini, Gabriella; Marasca, Claudio | |
Reply to 'A case of dystrophic epidermolysis bullosa pruriginosa treated with dupilumab' by Caroppo et al | 1.7 Commento, erratum, replica e simili | 2022 | Martora, F; Fabbrocini, G; Nappa, P; Marasca, C; Patruno, C; Scalvenzi, M; Napolitano, M | |
Skin reaction after SARS-CoV-2 vaccines Reply to 'cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: A real-life multicentre experience' | 1.7 Commento, erratum, replica e simili | 2022 | Martora, Fabrizio; Villani, Alessia; Marasca, Claudio; Fabbrocini, Gabriella; Potestio, Luca | |
Teledermatology in the management of hidradenitis suppurativa: Should we improve this service? | 1.1 Articolo in rivista | 2022 | Ruggiero, Angelo; Marasca, Claudio; Fabbrocini, Gabriella; Villani, Alessia; Martora, Fabrizio | |
Ultrasound: an indispensable tool to evaluate the outcome of surgical approaches in patients affected by hidradenitis suppurativa | 1.1 Articolo in rivista | 2020 | Marasca, Claudio; Marasca, Dario; Megna, Matteo; Annunziata, MARIA CARMELA; Fabbrocini, Gabriella | |
Strategies adopted in a southern Italian referral centre to reduce adalimumab discontinuation: comment on 'Can we increase the drug survival time of biologic therapies in hidradenitis suppurativa?' | 1.1 Articolo in rivista | 2022 | Martora, Fabrizio; Marasca, Claudio; Fabbrocini, Gabriella; Ruggiero, Angelo |